Jena D. French

Also affiliated with University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, University of Colorado Denver

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitors”.

Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.01.27.635086

N/A

0.165DataRank · unranked

2 citations

Jillian Greenberg, Tianyue Qin, Soo-Yeon Im, Gnana P. Krishnamoorthy, Laura Boucai +12 more

Tumor-infiltrating T Lymphocytes Recognize Thyroid-specific Proteins and Neo-antigens in Follicular Cell-derived Thyroid Cancers

The Journal of Clinical Endocrinology & Metabolism(2025)10.1210/clinem/dgaf639

N/A

0DataRank · unranked

3 citations

Jacob Calhoun, Paul J. Norman, Noah Cline, Katherine M. Kichula, Ticiana D.J. Farias +6 more

Loss of tumor cell MHC class II drives MAPK inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancers

Journal of Clinical Investigation(2025)10.1172/jci191781

N/A

0DataRank · unranked

0 citations

Jillian Greenberg, Tianyue Qin, Soo-Yeon Im, Gnana P. Krishnamoorthy, Laura Boucai +12 more